Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study for the Safety and Efficacy of Intravenous Infusion With NGGT002 in Adults Patients With Phenylketonuria

NCT06687733 is registered in ClinicalTrials.gov with NGGT (Suzhou) Biotechnology Co., Ltd. as lead sponsor.

NCT NCT06687733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06687733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study for the Safety and Efficacy of Intravenous Infusion With NGGT002 in Adults Patients With Phenylketonuria
Lead sponsor
NGGT (Suzhou) Biotechnology Co., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 16, 2024
Completion date
June 11, 2030
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

phenylketonurias